Happy New Year 🎆
Visikol
Biotechnology Research
Hampton, New Jersey 5,739 followers
Advanced imaging, digital pathology and 3D cell culture drug discovery services.
About us
Visikol is a contract research services company that is focused on accelerating the drug discovery and development process through providing its clients with advanced tissue imaging and advanced cell culture services. Today, Visikol counts all twenty of the top twenty pharmaceutical companies as clients and has been instrumental in dozens of drug discovery programs. The company provides end-to-end services that include 3D tissue imaging, multiplex tissue imaging, digital pathology, high content imaging, 2D cell culture assays, 3D cell culture assays and ex vivo tissue slice assays. Visikol’s expertise lies in both transforming tissues into actionable insights as well as bridging the gap between in vitro assays and in vivo results through the use of best-in-class cell culture models. In addition to its services, Visikol sells a suite of tissue clearing reagents and kits as well as the HUREL® Micro Liver portfolio of primary hepatocyte liver models.
- Website
-
http://visikol.com
External link for Visikol
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Hampton, New Jersey
- Type
- Privately Held
- Founded
- 2016
- Specialties
- drug discovery, high throughput screening, high content screening, whole mount imaging, 3D cell cultures, in vitro assays, confocal microscopy, antibody penetration, organoids, and digital pathology
Locations
-
Primary
53 Frontage Road
Shelbourne Building, Suite #120
Hampton, New Jersey 08827, US
Employees at Visikol
Updates
-
One of the key steps in the drug discovery process is high-throughput screening, which allows researchers to test large numbers of compounds quickly and efficiently. This is where Visikol comes in, read more here -->https://hubs.ly/Q02YYMSW0 #Visikol #DrugDiscovery #HighThroughputScreening
-
New to Visikol's offerings and services? View our convenient overview here--> https://hubs.ly/Q02YXZMD0
-
2024 projects are coming to an end, but planning for 2025 is just beginning. View our catalog with our offerings here --> https://hubs.ly/Q02YXpJf0
-
In recent years, there has been a growing interest in the use of in vitro models as an alternative to in vivo studies for drug development. In this blog post, we will explore the use of in vitro models, such as Visikol’s BBB permeability assay, as a more cost-effective and ethical approach to drug development. Read more here --> https://hubs.ly/Q02YWl4m0 #Visikol #BloodBrainBarrier #InVitroModels
In Vitro Models: An Alternative to In Vivo Studies
https://visikol.com
-
One of the key benefits of our in vitro Immuno-Oncology Immune Cell Infiltration assay is its ability to create 3D cell culture models that are more biologically relevant and allow for proper assessment of immunotherapies designed to promote immune cell response to tumor cells. Read more here --> https://hubs.ly/Q02YVVRh0 #Visikol #ImmuneCellInfiltration #InVitroAssay
How Our In Vitro Immuno-Oncology Immune Cell Infiltration Assay Can Accelerate Drug Discovery
https://visikol.com
-
HUREL Human Pool™ Coculture system is a flexible less labor intensive Hepatocyte culture system when compared to other reported methodologies. View the ' Understanding The Performance Of Cellular Models For Intrinsic Clearance Determination: Case Studies For Assessment Of Low-Turnover Compounds Using HUREL Human Pool Coculture System' poster by clicking here --> https://hubs.ly/Q02WlQfz0 #Visikol #HUREL #CoCultureSystem
Posters - Visikol
https://visikol.com
-
One critical step in the IHC process is antigen retrieval, which involves treating tissue samples to expose antigens that may be masked by fixation. Understanding how pH can alter antigen retrieval is a fundamental aspect of IHC and contributes to advancing research in biology and medicine. Read more here --> https://hubs.ly/Q02Wlt9P0 #Visikol #IHC #AntigenRetrieval
The Impact of pH on Antigen Retrieval in Immunohistochemistry
https://visikol.com